Download PDF
October 29, 2013

Lynn L. Bergeson, “FDA Finds Current Regulatory Review Processes Protect Public from Risks of Nanomaterials,” Nanotechnology Now, October 29, 2013.

Bergeson & Campbell, P.C.

The U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) posted a blog item on October 24, 2013, concerning the use of nanotechnology to develop new drugs.